Clinical-Pathologic Spectrum of Drug-Induced Liver Disease Acute hepatitis acetaminophen isoniazid troglitazone Chronic hepatitis alpha methyldopa diclofenac nitrofurantoin Acute cholestasis chlorpromazine sulindac Chronic cholestasis chlorpromazine Fibrosis methotrexate NASH amiodarone Microvesicular steatosis valproic acid Veno-occlusive disease cyclophosphamide busulfan azathroprine For questions, please call USC Center for Liver Disease (323) 442-5908 Return to Liver Newsletter		Home Page   Areas of Expertise  Bloodless Surgery  Liver Transplantation  Live Donor Liver Transplant  Liver Surgery  Pancreatic Surgery  Gallbladder/Bile Duct Surgery  Portal Hypertension Surgery  Radio Frequency Ablation  Endoscopic Retrograde    Cholangiopancreatography  Pediatric Surgery    and Transplant   Information for Patients  Transplant Patient Guide  Long-Term Transplant Care  Patient Support Groups  Financial Considerations  Liver Glossary  About the USC    University Hospital   Features  What's New  Research and Development  Liver Newsletter  Downloads   General Information  Faculty and Staff  Web Links  Site Map  Contact Us   Search this site
USC Liver Transplant Program and Center for Liver Disease 1510 San Pablo Street, Suite 200, Los Angeles CA 90033-4612 Phone: (323) 442-5908     Fax: (323) 442-5721 E-mail: uscliver@surgery.hsc.usc.edu